Integrated Diagnostics (LON:IDHC) Reaches New 52-Week Low – Here’s Why

Integrated Diagnostics Holdings plc (LON:IDHC – Get Free Report)’s stock price hit a new 52-week low during trading on Thursday. The company traded as low as GBX 0.45 and last traded at GBX 0.46, with a volume of 71,464 shares. The stock had previously closed at GBX 0.46.

Integrated Diagnostics Stock Performance

The company’s 50-day moving average price is GBX 0.52 and its two-hundred day moving average price is GBX 0.56. The company has a debt-to-equity ratio of 42.91, a quick ratio of 0.75 and a current ratio of 1.67. The stock has a market cap of £2.84 million, a PE ratio of 0.00, a PEG ratio of 7.65 and a beta of 0.44.

Integrated Diagnostics Company Profile

(Get Free Report)

IDH is a leading diagnostics services provider in the Middle East and Africa offering a broad range of clinical pathology and
radiology tests to patients in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan. The Group’s core brands include Al Borg, Al Borg
Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Echo-Lab (Nigeria), Ultralab and Al Mokhtabar Sudan (both in Sudan),
and Biolab KSA (Saudi Arabia). With over 40 years of experience, a long track record for quality and safety has earned the Company
a trusted reputation, as well as internationally recognised accreditations for its portfolio of over 3,000 diagnostics tests.

Featured Articles

Receive News & Ratings for Integrated Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.